Search Results 3721-3730 of 26230 for oral

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  2. Joaquin Sanchez-Sotelo, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    2019 First Award for Oral Presentation at 20th General Meeting ISOLS 2019 for "Comparison of Reconstructive Techniques Following Oncologic Intraarticular ...

  3. Face-lift - Doctors & Departments - Mayo Clinic

    In: Oral and Maxillofacial Surgery. 3rd ed. St. Louis, Mo.: Elsevier; 2018. https://www.clinicalkey.com. Accessed July 29, 2018. Chaffoo RA. Complications ...

  4. Ipratropium (nasal route) - Side effects & dosage - Mayo Clinic

    The 0.03% nasal solution is used to relieve a runny nose caused by allergic and nonallergic perennial rhinitis. However, it does not relieve nasal congestion, ...

  5. Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 - Mayo Clinic

    ... oral anticoagulants is not an exclusion if estimated GFR > 30 ml/min). Seizures at stroke onset if it precludes obtaining an accurate baseline NIHSS ...

  6. Marie F. Grill, M.D. - Doctors and Medical Staff - Mayo Clinic

    Third Place Oral PresentationAcademic Excellence Day, St. Joseph's Hospital and Medical Center. 2009. Resident Symposium ScholarshipAmerican Neurological ...

  7. How safe and effective are new drugs for stroke prevention? - Mayo Clinic News Network

    — For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation. Warfarin use is ...

  8. First FDA-approved retinal gene therapy available at Mayo Clinic

    Evaluating treatment for Stargardt disease. Retinal dystrophies associated with rare disease-causing genetic variants. Evaluating oral treatments in patients ...

  9. A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease - Mayo Clinic

    * Any ongoing treatment with systemic immunosuppressants, systemic corticosteroids, or use of oral budesonide in the 12 weeks before screening. * Ongoing ...

  10. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

    Effective forms of contraception are defined as hormonal oral contraceptives, injectables, patches, intrauterine devices, double-barrier methods (eg ...